Home›People›Tim Fischell
Tim Fischell

Tim Fischell

Chief Medical Officer and director at Vantis Vascular. Also an executive officer and director at Ablative Solutions and a director at Aseko.

ExecutiveDirectorRoles at 3 startups
Updated Nov 10, 2026·Latest SEC filing Jul 10, 2026·Suggest an edit

About Tim Fischell

Tim Fischell is a chief medical officer and director at Vantis Vascular.

Form D filings also name Tim Fischell as an executive officer and director at Ablative Solutions and a director at Aseko.

Tim Fischell first appears on SEC filings in 2011.

Experience

This experience comes from Tim Fischell's profile and from SEC filings. For roles taken from filings, the years are when the filings name Tim Fischell in the role, so the role may have started earlier or lasted longer.

Vantis Vascular, Inc. Current
Chief Medical Officer and director
2018 – Present · San Jose, CA
Develops medical devices for cardiologists treating complex blood vessel conditions.
Western Michigan University Current
Clinical Professor of Medicine
2015 – Present
Ablative Solutions, Inc. Current
CMO (2011 – Present)
Director
2011 – Present · Wakefield, MA
Michigan State University Current
Professor of Medicine
1998 – Present
Borgess Medical Center Current
Director Cardiovascular Research
1996 – Present
Angel Medical Systems
Chief Medical Officer & Co-founder
2004 – 2018
Aseko, Inc.
Director
2011 – 2016 · Atlanta, GA
Through Glytec, provides insulin management software to healthcare providers.
Abbott Vascular
Scientific Advisory Board
2008 – 2016
Ostial Solutions
Medical Director
2006 – 2011
Cordis
Scientific Advisory Board
1999 – 2009
Vanderbilt University Medical Center
Director Cardiac Cath Labs and Interventional Cardiology
1992 – 1996

Key Colleagues at Startups

The people Tim Fischell works with at each company, as listed on that company's latest Form D.

Vantis Vascular, Inc. · Form D, Jul 10, 2026
LP
Len Pinchuk
Director
Frank Saltiel
Frank Saltiel
Chief Clinical Officer and director
Gary McCord
Gary McCord
Chief Commercial Officer
Marc Monahan
Marc Monahan
Chief Financial Officer
Mike Mirizzi
Mike Mirizzi
Chief Technology Officer
Jason Turner
Jason Turner
Chief Executive Officer and director
Ablative Solutions, Inc. · Form D, Jan 8, 2019
NH
Nicole Haratani
Executive officer
DF
GP
Geoff Pardo
Director
PT
DG
Dale Grogan
Director
PB
Paul Buckman
Director
MF
Aseko, Inc. · Form D, Mar 21, 2016
JB
John Beneke
Executive officer
RL
Robert Leonard
Executive officer and director
CP
Cheryl Pegus
Director
RB
Robby Booth
Executive officer
RM
Raymie McFarland
Executive officer
JD
Joseph Diver
Executive officer
LV
Lynn Vogel
Director
PT
Phillip Torrence
Asst. Secretary
PF
MN
SG
DF
Daniel Frank
Executive officer and director
MP
Megan Pietropaolo
Executive officer

Sources

  1. SECVantis Vascular, Inc. Form D, filed Jul 10, 2026
  2. SECAblative Solutions, Inc. Form D, filed Jan 8, 2019
  3. SECAseko, Inc. Form D, filed Mar 21, 2016